Adis Journals
Summary Slide.png (54.96 kB)

Economic Evaluation of Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine for the Treatment of First-Line Advanced Metastatic Triple-Negative Breast Cancer in China: Using Markov Model and Partitioned Survival Model

Download (54.96 kB)
posted on 2020-07-03, 08:49 authored by Mingjun Rui, Fenghao Shi, Ye Shang, Rui Meng, Hongchao Li

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.